Get started
Johnson & JohnsonJohnson & JohnsonJohnson & Johnson

Johnson & Johnson

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Options Bonds

JNJ trade ideas

JOHNSON & JOHNSON (JNJ)In my work, I always try to combine fundamental analysis and technical analysis. They are both important, especially on a topic as important as the covid vaccine. Johnson & Johnson is about to be marketed, after the approval of the EMA on 11 March. Exactly after the announcement, I bought the stock. The JnJ vaccine has a much lower distribution cost than Pfizer since it can be stored at refrigerator temperatures, like AstraZeneca. The difference is in the prestige and history that the company has. Moreover, the share according to the average of analysts, still has ample room for growth, with an average target of $ 185 and a second "high" at $ 200. Technically speaking, the price bounced off the bullish support trendline on Thursday, March 4th, and then broke the resistance trendline on the 12th, exactly the day after the announcement of the EMA's approval. The trend is clearly bullish, but, even keeping in mind the analysts' opinion, I believe the first target in area 170 is more likely. If everything goes well with the vaccine, the analyst targets could be greatly raised. It is a different trade, to be constantly monitored with a trailing stop, in case there will be any hitches or cases of a block, as happened for AstraZeneca. Such an open market scenario would cause a crash, so you have to be ready to get out quickly. Lazy Bull 1st target: 170 2nd target: 180 3rd target: 200 DISCLAIMER: I am not a financial advisor nor a CPA. These posts, videos, and any other contents are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.
NYSE:JNJLong
by LazyBull5
2
$JNJ has baby fetus' in their vaccine - look it up$JNJ Said they don't have any evidence that the blood clots are related to the vaccine. That's like saying Hunter Biden doesn't smoke crack. Anyway, even though JNJ has alot of bad news surrounding them, it looks like it's forming an Ascending triangle. I am looking to play the ER runup. ER is on 4/20. Last earnings it ran up the day before and day of earnings. I don't think that it will run on both days due to uncertainty. I have currently have 1 $162.5c. My PT is $164-165. 4HR MACD curling up!
NYSE:JNJLong
by DarthTrador
JNJ- POSSIBLE PUT OPTIONS - MAY 21ST 0.84 CONTRACTS $150All, In semi recent news it's very possible JNJ loses the COVID contracts or at least long enough to take a solid tumble. IF it breaks into the red zone it should trigger a loss of a high and break trend downwards again to $145-$132 level. As always wait for conformation of breaking under first level and watch options volume/contracts for changes in price and news. JNJ in a prime spot to be shorted. Also you can always cover with calls.
NYSE:JNJShort
by DigitalData
3
Johnson & Johnson should stick to baby wipes.....Vaccine Recall!With the news that the CDC is pausing J&J vaccine distribution due to blood clot issues. I'm assuming we should see it tank at the open? You're guess is as good as mine. In my opinion if we see price drop it should be a good time to buy, because everyone else is selling. The level I'm interested in is $147-$150. It is an untested point of control where institutions may have some buy orders sitting. Watch for an ABCD on the line chart (close to close) for entry. We may not break the 2021 high, but if the March equal highs remain untouched, I would look to enter because there is still possibly liquidity there. $150 should give a nice reaction if we hit it while those highs are untouched. Let's Elevate, Gio
NYSE:JNJ
by elevatedinvestor
JONSON & JONSON D1Johnson & Johnson Company is one of the leaders in the production and sale of hygiene and care products. The shares of this company are among the first echelon of the American market. And they almost always provide stability for investments. After the market collapse at the beginning of the epidemic, the company's shares managed to reach a new historical maximum in their price. Now the asset has undergone a completely logical correction, after which we can most likely expect the uptrend to recover. The active development of the disease around the world has led to a number of new lockdowns and quarantine restrictions. The violence of all the planet is trying to protect itself as much as possible from the disease, and therefore takes all measures for hygienic prevention. Of course, there will be an increased demand for the products of the Johnson and Johnson company at this time. What will entail an increase in profits and, of course, an increase in the company's shares !!!
NYSE:JNJLong
by TradingForProfitPro
2
$JNJ will bounce - Dip opportunityI love JNJ long and believe that they are going to be fine with the recent COVID-related dip. Their vaccine could do more damage than AstraZeneca's and governments will still buy it in order to herd the sheep. You need to understand that JNJ is so much more than a vaccine company. Expect this stock to go back up to the $167 level, as well as breaking the $170 level as well. A great swing trade (buy covid dips), and I also love this long-term. Lots of money to be made here! *Not a financial advisor. **Don't judge me on my winners. Judge me on my losers, because there are so few.
NYSE:JNJLong
by kambach
6